SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-014273
Filing Date
2020-03-30
Accepted
2020-03-30 17:05:22
Documents
4
Period of Report
2020-03-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ubx-8k_20200330.htm 8-K 36846
2 EX-10.1 ubx-ex101_7.htm EX-10.1 127140
3 EX-99.1 ubx-ex991_6.htm EX-99.1 13838
4 GRAPHIC gro32gfqz3t4000001.jpg GRAPHIC 3861
  Complete submission text file 0001564590-20-014273.txt   184705
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 20758058
SIC: 2834 Pharmaceutical Preparations